These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18295507)

  • 1. COX-2 oxidative metabolism of endocannabinoids augments hippocampal synaptic plasticity.
    Yang H; Zhang J; Andreasson K; Chen C
    Mol Cell Neurosci; 2008 Apr; 37(4):682-95. PubMed ID: 18295507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons.
    Sang N; Zhang J; Chen C
    J Physiol; 2006 May; 572(Pt 3):735-45. PubMed ID: 16484297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 in synaptic signaling.
    Yang H; Chen C
    Curr Pharm Des; 2008; 14(14):1443-51. PubMed ID: 18537667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice.
    Pan B; Wang W; Zhong P; Blankman JL; Cravatt BF; Liu QS
    J Neurosci; 2011 Sep; 31(38):13420-30. PubMed ID: 21940435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid signaling and synaptic plasticity.
    Sang N; Chen C
    Neuroscientist; 2006 Oct; 12(5):425-34. PubMed ID: 16957004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation.
    Zhang J; Chen C
    J Biol Chem; 2008 Aug; 283(33):22601-11. PubMed ID: 18534982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE).
    Diana MA; Marty A
    Br J Pharmacol; 2004 May; 142(1):9-19. PubMed ID: 15100161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum.
    Maejima T; Oka S; Hashimotodani Y; Ohno-Shosaku T; Aiba A; Wu D; Waku K; Sugiura T; Kano M
    J Neurosci; 2005 Jul; 25(29):6826-35. PubMed ID: 16033892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity.
    Sang N; Zhang J; Chen C
    J Neurochem; 2007 Sep; 102(6):1966-1977. PubMed ID: 17539917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid signaling and synaptic plasticity in the brain.
    Zhu PJ
    Crit Rev Neurobiol; 2006; 18(1-2):113-24. PubMed ID: 17725514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoids restrict hippocampal long-term potentiation via CB1.
    Slanina KA; Roberto M; Schweitzer P
    Neuropharmacology; 2005 Oct; 49(5):660-8. PubMed ID: 15950248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Input-specific plasticity at excitatory synapses mediated by endocannabinoids in the dentate gyrus.
    Chiu CQ; Castillo PE
    Neuropharmacology; 2008 Jan; 54(1):68-78. PubMed ID: 17706254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus.
    Hashimotodani Y; Ohno-Shosaku T; Kano M
    J Neurosci; 2007 Jan; 27(5):1211-9. PubMed ID: 17267577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of excitability and plasticity by endocannabinoids and PKA in developing hippocampus.
    Yasuda H; Huang Y; Tsumoto T
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3106-11. PubMed ID: 18287074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus.
    Edwards DA; Zhang L; Alger BE
    Proc Natl Acad Sci U S A; 2008 Jun; 105(23):8142-7. PubMed ID: 18523004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoids in striatal plasticity.
    Lovinger DM; Mathur BN
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1(Suppl 1):S132-4. PubMed ID: 22166411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus.
    Stempel AV; Stumpf A; Zhang HY; Özdoğan T; Pannasch U; Theis AK; Otte DM; Wojtalla A; Rácz I; Ponomarenko A; Xi ZX; Zimmer A; Schmitz D
    Neuron; 2016 May; 90(4):795-809. PubMed ID: 27133464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid signaling: sleep, synaptic plasticity, and neuroprotection.
    Chen C; Bazan NG
    Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):65-76. PubMed ID: 16099392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity.
    Kotilinek LA; Westerman MA; Wang Q; Panizzon K; Lim GP; Simonyi A; Lesne S; Falinska A; Younkin LH; Younkin SG; Rowan M; Cleary J; Wallis RA; Sun GY; Cole G; Frautschy S; Anwyl R; Ashe KH
    Brain; 2008 Mar; 131(Pt 3):651-64. PubMed ID: 18292081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses.
    Zimmermann T; Bartsch JC; Beer A; Lomazzo E; Guggenhuber S; Lange MD; Bindila L; Pape HC; Lutz B
    Neuropsychopharmacology; 2019 Jul; 44(8):1377-1388. PubMed ID: 30532004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.